Ether à go-go potassium channels as human cervical cancer markers

Cancer Research

Volumn 64, Issue 19, 2004, Pages 6996-7001

  Farias, Luz María Barajas ^a   Ocaña, Deysi Bermúdez ^a   Díaz, Lorenza ^b   Larrea, Fernando ^b   Avila Chávez, Euclides ^b   Cadena, Adriana ^a   Hinojosa, Luz María ^c   Lara, Gerardo ^c   Villanueva, Luis Alberto ^c   Vargas, Carlos ^c   Hernández Gallegos, Elizabeth ^a   Camacho Arroyo, Ignacio ^d   Dueñas González, Alfonso ^e   Pérez Cárdenas, Enrique ^e   Pardo, Luis A ^f   Morales, Angélica ^b   Taja Chayeb, Lucía ^e   Escamilla, Juan ^a   Sánchez Peña, Carmen ^a   Camacho, Javier ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^c GEA Gonzalez Hospital   (Mexico)

^d Universidad Nacional Autonoma de Mexico Facultad de Quimica   (Mexico)

^e INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^f MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM; POTASSIUM CHANNEL HERG; TUMOR MARKER; KCNH1 PROTEIN, HUMAN; MESSENGER RNA; POTASSIUM CHANNEL;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; MEMBRANE CURRENT; PATCH CLAMP; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; UTERINE CERVIX CANCER; BIOPSY; BIOSYNTHESIS; ELECTROCHEMISTRY; GENE EXPRESSION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; UTERINE CERVIX TUMOR;

BIOPSY; ELECTROCHEMISTRY; ETHER-A-GO-GO POTASSIUM CHANNELS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; POTASSIUM CHANNELS; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 4944252457     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-1204     Document Type: Article

References (20)

1. Hille B. Ion channels of excitable membranes. 3rd. ed. Massachusetts: Sinauer Associates Inc.; 2001.
2. Brüggemann A, Stühmer W, Pardo LA. Mitosis-promoting factor-mediated suppression of a cloned delayed rectifier potassium channel expressed in Xenopus oocytes. Proc Natl Acad Sci USA 1997;94:537-42.
3. + channels. J Cell Biol 1998;143:767-75.
4. Meyer R, Heinemann SH. Characterization of an eag-like potassium channel in human neuroblastoma cells. J Physiol 1998;508:49-56.
5. Occhiodoro T, Bernheim L, Liu J, et al. Cloning of a human ether-a-go-go potassium channel expressed in myoblasts at the onset of fusion. FEBS Lett 1998;434:177-82.
6. h-eag, contributes to the hyperpolarization of human fusion-competent myoblasts. J Physiol 1998;512:317-23.
7. Camacho J, Sánchez A, Pardo LA, Stühmer W. Cytoskeletal interactions determine the electrophysiological properties of human EAG potassium channels. Pflugers Arch 2000;441:167-74.
8. Crociani O, Guasti L, Balzi M, et al. Cell cycle-dependent expression of HERG1 and HERG1B isoforms in tumor cells. J Biol Chem 2003;278:2947-55.
9. + channels. EMBO J 1999;18:5540-7.
10. Meyer R, Schönherr R, Gavrilova-Ruch O, Wohlrab W, Heinemann SH. Identification of ether à go-go and calcium-activated potassium channels in human melanoma cells. J Membr Biol 1999;171:107-15.
11. + channel. Receptors Channels 2001;7:345-56.
12. Gavrilova-Ruch O, Schönherr K, Gessner G, et al. Effects of imipramine on ion channels and proliferation of IGR1 melanoma cells. J Membr Biol 2002;188:137-49.
13. Pardo L, Hemmerlein B, Sánchez A, et al. Eag1 potassium channel as cancer therapy target. Eur J Cancer 2002;38 Suppl 7:104.
14. + current highly conserved in tumors of different histogenesis: a selective advantage for cancer cells? Cancer Res 1998;58:815-22.
15. + chanels in neoplastic hematopoietic cells. J Biol Chem 2002;277:18528-34.
16. Pillozzi S, Brizzi MF, Balzi M, et al. HERG potassium channels are constitutively expressed in primary human acute myeloid leukemias and regulate cell proliferation of normal and leukemic hemopoietic progenitors. Leukemia 2002;16:1791-8.
17. Cherubini A, Taddei GL, Crociani O, et al. HERG potassium channels are more frequently expressed in human endometrial cancer as compared to non-cancerous endometrium. Br J Cancer 2000;83:1722-9.
18. Bellone S, Palmieri M, Gokden M, et al. Selection of HER-2/neu-positive tumor cells in early stage cervical cancer: implications for Herceptin-mediated therapy. Gynecol Oncol 2003;91:231-40.
19. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 1981;391:85-100.
20. 2+ regulates activation of rat eag potassium channel. Pflugers Arch 1996;432: 301-12.